Literature DB >> 11916919

The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations : distinct metabolic effects of two fat compartments.

Miriam Cnop1, Melinda J Landchild, Josep Vidal, Peter J Havel, Negar G Knowles, Darcy R Carr, Feng Wang, Rebecca L Hull, Edward J Boyko, Barbara M Retzlaff, Carolyn E Walden, Robert H Knopp, Steven E Kahn.   

Abstract

Obesity is associated with insulin resistance, particularly when body fat has a central distribution. However, insulin resistance also frequently occurs in apparently lean individuals. It has been proposed that these lean insulin-resistant individuals have greater amounts of body fat than lean insulin-sensitive subjects. Alternatively, their body fat distribution may be different. Obesity is associated with elevated plasma leptin levels, but some studies have suggested that insulin sensitivity is an additional determinant of circulating leptin concentrations. To examine how body fat distribution contributes to insulin sensitivity and how these variables are related to leptin levels, we studied 174 individuals (73 men, 101 women), a priori classified as lean insulin-sensitive (LIS, n = 56), lean insulin-resistant (LIR, n = 61), and obese insulin-resistant (OIR, n = 57) based on their BMI and insulin sensitivity index (S(I)). Whereas the BMI of the two lean groups did not differ, the S(I) of the LIR subjects was less than half that of the LIS group. The subcutaneous and intra-abdominal fat areas, determined by computed tomography, were 45 and 70% greater in the LIR subjects (P < 0.001) and 2.5- and 3-fold greater in the OIR group, as compared with the LIS group. Fasting plasma leptin levels were moderately increased in LIR subjects (10.8 +/- 7.1 vs. 8.1 +/- 6.4 ng/ml in LIS subjects; P < 0.001) and doubled in OIR subjects (21.9 +/- 15.5 ng/ml; P < 0.001). Because of the confounding effect of body fat, we examined the relationships between adiposity, insulin sensitivity, and leptin concentrations by multiple regression analysis. Intra-abdominal fat was the best variable predicting insulin sensitivity in both genders and explained 54% of the variance in S(I). This inverse relationship was nonlinear (r = -0.688). On the other hand, in both genders, fasting leptin levels were strongly associated with subcutaneous fat area (r = 0.760) but not with intra-abdominal fat. In line with these analyses, when LIS and LIR subjects were matched for subcutaneous fat area, age, and gender, they had similar leptin levels, whereas their intra-abdominal fat and insulin sensitivity remained different. Thus, accumulation of intra-abdominal fat correlates with insulin resistance, whereas subcutaneous fat deposition correlates with circulating leptin levels. We conclude that the concurrent increase in these two metabolically distinct fat compartments is a major explanation for the association between insulin resistance and elevated circulating leptin concentrations in lean and obese subjects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916919     DOI: 10.2337/diabetes.51.4.1005

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  101 in total

1.  Adipokine concentrations in nonobese women: a study of reproductive aging, body mass index, and menstrual cycle effects.

Authors:  Patricia A Rouen; Jane L Lukacs; Nancy E Reame
Journal:  Biol Res Nurs       Date:  2010-05-07       Impact factor: 2.522

Review 2.  Metabolic impact of body fat distribution.

Authors:  C Gasteyger; A Tremblay
Journal:  J Endocrinol Invest       Date:  2002-11       Impact factor: 4.256

3.  Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.

Authors:  R Coccurello; A Caprioli; O Ghirardi; R Conti; B Ciani; S Daniele; A Bartolomucci; A Moles
Journal:  Psychopharmacology (Berl)       Date:  2006-05-13       Impact factor: 4.530

4.  Plasma pancreatic polypeptide levels are associated with differences in body fat distribution in human subjects.

Authors:  J Tong; K M Utzschneider; D B Carr; S Zraika; J Udayasankar; F Gerchman; R H Knopp; S E Kahn
Journal:  Diabetologia       Date:  2006-12-15       Impact factor: 10.122

Review 5.  Leptin as a Mediator of Obesity-Induced Hypertension.

Authors:  Balyssa B Bell; Kamal Rahmouni
Journal:  Curr Obes Rep       Date:  2016-12

Review 6.  Comparative endocrinology of leptin: assessing function in a phylogenetic context.

Authors:  Richard L Londraville; Yazmin Macotela; Robert J Duff; Marietta R Easterling; Qin Liu; Erica J Crespi
Journal:  Gen Comp Endocrinol       Date:  2014-02-11       Impact factor: 2.822

7.  Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue.

Authors:  Susan A Phillips; Theodore P Ciaraldi; Deborah K Oh; Michelle K Savu; Robert R Henry
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-29       Impact factor: 4.310

8.  Developmental Programming: Impact of Gestational Steroid and Metabolic Milieus on Adiposity and Insulin Sensitivity in Prenatal Testosterone-Treated Female Sheep.

Authors:  Rodolfo C Cardoso; Almudena Veiga-Lopez; Jacob Moeller; Evan Beckett; Anthony Pease; Erica Keller; Vanessa Madrigal; Gregorio Chazenbalk; Daniel Dumesic; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2015-12-09       Impact factor: 4.736

9.  Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep.

Authors:  A Veiga-Lopez; J Moeller; D Patel; W Ye; A Pease; J Kinns; V Padmanabhan
Journal:  Endocrinology       Date:  2013-03-24       Impact factor: 4.736

10.  Relationships between plasma adiponectin and body fat distribution, insulin sensitivity, and plasma lipoproteins in Alaskan Yup'ik Eskimos: the Center for Alaska Native Health Research study.

Authors:  Anna V Goropashnaya; Johanna Herron; Mary Sexton; Peter J Havel; Kimber L Stanhope; Rosemarie Plaetke; Gerald V Mohatt; Bert B Boyer
Journal:  Metabolism       Date:  2009-01       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.